Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,122 | 26,543 | 42,186 | 53,962 | 65,824 |
| Receivables | 5,860 | 4,904 | 5,192 | 2,798 | 3,567 |
| Other current assets | 300 | 871 | 1,301 | 1,124 | 785 |
| TOTAL | $24,282 | $32,318 | $48,679 | $57,884 | $70,176 |
| Non-Current Assets | |||||
| Investments And Advances | 1,806 | 2,676 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 118 | 130 | 136 | 120 |
| TOTAL | $1,806 | $2,794 | $130 | $136 | $120 |
| Total Assets | $26,477 | $35,125 | $48,826 | $58,608 | $70,656 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,532 | 5,270 | 6,181 | 6,939 | 5,590 |
| Other current liabilities | 9 | 8 | 1,365 | 1,680 | 2,125 |
| TOTAL | $6,663 | $5,278 | $7,546 | $8,854 | $7,980 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,906 | $5,278 | $7,546 | $9,279 | $8,270 |
| Shareholders' Equity | |||||
| Common Shares | 102 | 102 | 102 | 8,160 | 10,794 |
| Retained earnings | -116,263 | -112,574 | -108,063 | -104,697 | -84,646 |
| Other shareholders' equity | 121,136 | 127,723 | 133,645 | 32,328 | 24,417 |
| TOTAL | $19,571 | $29,847 | $41,280 | $49,330 | $62,386 |
| Total Liabilities And Equity | $26,477 | $35,125 | $48,826 | $58,609 | $70,656 |